A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters

Journal of Pediatric Hematology/Oncology

Volumn 24, Issue 9, 2002, Pages 710-713

  Aquino, Victor M ^a,b   Sandler, Eric S ^a   Mustafa, Mahmoud M ^a   Steele, Jill W ^a   Buchanan, George R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PLASMINOGEN ACTIVATOR; UROKINASE;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FEVER; FLUSHING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS TISSUE;

ADOLESCENT; ADULT; ANTICOAGULANTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HEPARIN; HUMANS; INFANT; LEUKEMIA; LYMPHOMA; MALE; NEOPLASMS; PLASMINOGEN ACTIVATORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036898509     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200212000-00005     Document Type: Article

References (42)

1. Albanese CT and Wiener ES. Venous access in pediatric oncology patients. Semin Surg Oncol 1993;9:467-77.
2. Badley AD, Seckelberg JM, Wollan PC, et al. Infectious rates of central venous pressure catheters: Comparison between newly placed catheters and those that have been changed. Mayo Clin Proc 1996;71:838-46.
3. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Infect Dis J 1988;35:579-612.
4. Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13:233-8.
5. Harms D, Gortitz I, Lambrecht W, et al. Infectious risks of Broviac catheters in children with neoplastic disease: A matched pairs analysis. Pediatr Infect Dis J 1992;11:1014-8.
6. Johnson PR, Decker MD, Edwards KM, et al. Frequency of broviac catheter infections in pediatric oncology patients. J Infect Dis 1986;154:570-8.
7. Mirro J, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989;7:214-22.
8. Rackoff WR, Ge J, Sather HN, et al. Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: A report from the Children's Cancer Group. J Pediatr Hematol Oncol 1999;21:260-7.
9. Severien C, Nelson JD. Frequency of infections associated with implanted systems vs cuffed, tunneled silastic venous catheters in patients with acute leukemia. Am J Dis Child 1991;145:1433-8.
10. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac Hickman catheters and implantable venous devices. Am J Dis Child 1988;142:536-40.
11. Maki DG, Cobb L, Garman JK, et al. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: A prospective randomized multicenter trial. Am J Med 1988;85:307-14.
12. Schwartz C, Henrickson KJ, Raghmann K, et al. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990;8:1591-7.
13. Stephens LC, Haire WD, Tarantolo S, et al. Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC). Transfus Sci 1997:18:187-93.
14. Vassilomanolakis M, Plantaniotis G, Koumakis G, et al. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: A prospective study with short-course vancomycin prophylaxis. Bone Marrow Transplant 1995;15:77-80.
15. Rubie H, Juricic M, Claeyssens S, et al. Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer. Arch Dis Child 1995;72:325-9.
16. Younger JJ, Christensen GD, Bartley DL, et al. Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: Importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis 1987;156:548-54.
17. Van Hoff J, Berg AT, Seashore JH. The relationship between the thrombotic and infectious complications of central venous catheters. J Clin Oncol 1990;8:1255-62.
18. Raad II, Luna M, Khalil SA, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994;271:1014-6.
19. Herrmann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158:693-701.
20. Hawiger J, Hammond DK, Timmons S, et al. Interaction of human fibrinogen with staphylococci: Presence of a binding region on normal and abnormal fibrinogen variants and fibrinogen derivatives. Blood 1978;51:799-812.
21. Gabriel J. Fibrin sheaths in vascular access devices. Nurs Times 1997;93:56-7.
22. Fishbein JD, Friedman HS, Bennett BB, et al. Catheter-related sepsis refractory to antibiotics treated successfully with adjunctive urokinase infusion. Pediatr Infect Dis J 1990;9:676-8.
23. Ascher DP, Shoupe BA, Maybee D, et al. Persistent catheter-related bacteremia: Clearance with antibiotics and urokinase. J Pediatr Surg 1993;28:627-9.
24. Jones GR, Konsler GK, Dunaway RP, et al. Prospective analysis of urokinase in treatment of catheter sepsis in pediatric hematology-oncology patients. J Clin Oncol 1993;28:350-7.
25. Abbokinase Open-Cath. (Urokianse for Cathter Clearance). Package Insert. 1994; Abbott Laboratories:
26. FDA MedWatch. March 22, 1999.
27. Christensen ML, Hancock ML, Gattuso J, et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer 1993;72:2732-8.
28. Wiener E, McGuire P, Stolare CJH, et al. The CCSG prospective study of venous access devices: An analysis of insertions and causes for removal. J Pediatr Surg 1992;27:155-64.
29. Mueller BU, Skelton J, Callender DPE, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-8.
30. La Quaglia MP, Lucas A, Thaler HT. A prospective analysis of vascular access device-related infections in children. J Pediatr Surg 1992:27:840-2.
31. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1994;119:1168-74.
32. Greene JN. Catheter-related complications of cancer therapy. Infect Dis Clin North Am 1996;10:255-93.
33. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982;146:479-82.
34. Diaz-Mitoma F, Harding GKM, Hoban DJ, et al. Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagualse-negative staphylococci. J Infect Dis 1987;156:555-60.
35. Cheung AL, Fischetti VA. The role of fibrinogen in mediating staphylococcal adherence to fibers. J Surg Res 1991:50:150-5.
36. Quie PG and Belani KK. Coagulase-negative staphylococci adherence and persistence. J Infect Dis 1987;156:543-7.
37. Haire WD, Liberman RP, Lund GB, et al. Obstructed central venous catheters: Restoring function with a 12-hour infusion of low-dose urokinase. Cancer 1990; 66:2279-85.
38. Withrop AL, Wesson DE. Urokinase in the treatment of occluded central venous catheters in children. J Pediatr Surg 1984;19:536-8.
39. Teirstein PS, Mann JT, Cundey PE, et al. Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. Am J Cardiol 1999;83:1623-8.
40. Mayo DJ. Administering urokinase for catheter clearance. Nursing 1998;28:50-2.
41. LaQuagia MP, Caldwell C, Lucas A, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children. J Ped Surg 1994;29:742-5.
42. Jones GR, Dillon PW, Bagnall-Reeb H, et al. Urokinase for the prevention of central venous catheter occlusions and infections: Results of the Children's Cancer Group Study CCG-S921. J Pediatr Hematol Oncol 2001;23:A26.